SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-017321
Filing Date
2023-11-02
Accepted
2023-11-02 07:45:30
Documents
55
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cgtx-20230930x10q.htm   iXBRL 10-Q 1322430
2 EX-31.1 cgtx-20230930xex31d1.htm EX-31.1 16711
3 EX-31.2 cgtx-20230930xex31d2.htm EX-31.2 17000
4 EX-32.1 cgtx-20230930xex32d1.htm EX-32.1 10070
5 EX-32.2 cgtx-20230930xex32d2.htm EX-32.2 10058
  Complete submission text file 0001558370-23-017321.txt   5128772

Data Files

Seq Description Document Type Size
6 EX-101.SCH cgtx-20230930.xsd EX-101.SCH 31112
7 EX-101.CAL cgtx-20230930_cal.xml EX-101.CAL 39760
8 EX-101.DEF cgtx-20230930_def.xml EX-101.DEF 122718
9 EX-101.LAB cgtx-20230930_lab.xml EX-101.LAB 337615
10 EX-101.PRE cgtx-20230930_pre.xml EX-101.PRE 245666
49 EXTRACTED XBRL INSTANCE DOCUMENT cgtx-20230930x10q_htm.xml XML 763661
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40886 | Film No.: 231370125
SIC: 2836 Biological Products, (No Diagnostic Substances)